Smartkarma Originals
Asian Healthcare - Coming of Age
This Smartkarma Originals Insight highlights 20 leading unlisted healthcare companies in Asia, mainly in digital healthcare and biopharma, that are...
871 Views
Full Details & Current Designation List - Short-Selling Restriction Rule Change in Korea
It is now official that we have a new short-selling restriction rule, which is effective as of March 11. For the existing regulations, we now have...
346 Views
CV Note: Macrogen (038290 KQ)
"Korea’s #1 and the world’s #5 NGS player" The world’s 5th ranked DNA sequencing service provider. Growing NGS (Next Generation Sequencing) market...
573 Views
NPS' Passive Investing May Come to an End - Impact on Celltrion's KOSPI Move
Interesting news came out for Celltrion Inc (068270 KS). Celltrion's retail investors are now demanding a KOSPI move from KOSDAQ. Nearly 10,000...
1.4k Views
ASTA IPO Part 2 - Growth Potential & Appropriate Valuation Level
* In Part 2 (as below), I summarized the company's growth potential and appropriate valuation level.Who is ASTA again? The company is a biomass...
534 Views